D
Ventura
News Letter
| Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 22 Oct 2026 | Market Movement |
Ventura
|
Daily Note
|
||||||||
| 22 Oct 2026 | Aditya Birla Sun Life AMC |
BOB Capital Markets Ltd.
|
904.15 | 1135.00 | 904.15 | 25.53 |
Buy
|
Aditya Birla Sun Life Amc (BUY): Cost pressure weighs on margin; Maintain BUYRevenue grew 4.9% YoY …
BOB Capital Markets Ltd.
Revenue grew 4.9% YoY while EBITDA degrew 5.1% YoY, owing to high ESOP costs, provision reversal in Q2FY26 and passive team hiring
|
|||
| 22 Oct 2026 | Eternal |
Axis Direct
|
304.45 | 390.00 | 304.45 | 28.10 |
Buy
|
||||
| 22 Oct 2026 | World Economy and Markets |
Axis Direct
|
Daily Note
|
||||||||
| 22 Oct 2026 | Chemicals & Petrochemicals |
Deven Choksey
|
Sector Update
|
Capacity-led growth, pricing tailwinds: Q2 marks a broad-based recovery in chemicals
Deven Choksey
Q2FY27 marks a stronger recovery phase for Indian specialty chemicals, with aggregate revenue growth estimated at ~25–30% YoY, driven by volume normalisation, new capacity ramp-ups and improving fluorochemical and amine pricing.
|
|||||||
| 22 Oct 2026 | Eternal |
ICICI Securities Limited
|
304.45 | 425.00 | 312.35 (-2.53%) | 39.60 |
Buy
|
Revenues and earnings beat in Q2FY27; foraying into AI applications
ICICI Securities Limited
The upgrade in quick commerce (QC) store guidance to ~5,000 (nos.) by FY28 is indicative of management’s belief that the lines between e-commerce and QC are blurring.
|
|||
| 22 Oct 2026 | Indian Hotels Company |
ICICI Securities Limited
|
782.30 | 969.00 | 753.00 (3.89%) | 23.87 |
Buy
|
Stellar quarter; strong pipeline to fuel growth
ICICI Securities Limited
Q2FY27 saw Indian Hotels Co. Ltd. (IHCL) delivering commendable performance, with 22%/24% YoY consolidated revenue/EBITDA growth (25% domestic LTL RevPAR) in spite of geopolitical disruptions.
|
|||
| 22 Oct 2026 | Oberoi Realty |
ICICI Securities Limited
|
1625.20 | 2151.00 | 1647.40 (-1.35%) | 32.35 |
Buy
|
||||
| 22 Oct 2026 | Vishal Mega Mart |
ICICI Securities Limited
|
87.99 | 150.00 | 90.00 (-2.23%) | 70.47 |
Buy
|
Holding price, winning share
ICICI Securities Limited
Vishal Mega Mart’s (VMM) Q2FY27 revenue grew 14% YoY, with reported same-store-sales growth (SSSG) of 5.4%. EBITDA and PAT rose 4.4% and 3.7% YoY, respectively, while margins were affected by the shift in festive calendar this year, higher staff costs, and gross margin pressure.
|
|||
| 22 Oct 2026 | M&M Financial |
ICICI Securities Limited
|
287.60 | 415.00 | 297.45 (-3.31%) | 44.30 |
Buy
|
RoA nearing medium-term goal of 2.5%; growth acceleration continues
ICICI Securities Limited
Mahindra & Mahindra Financial Services (MMFS) demonstrated sustained improvement across business parameters, including growth, margins and asset quality, in Q2FY27; thus, validating the successful adoption of its revamped techled business model.
|
|||
| 22 Oct 2026 | M&M Financial |
Emkay
|
287.60 | 370.00 | 297.45 (-3.31%) | 28.65 |
Buy
|
Healthy 2Q; margins and regulations key to watch
Emkay
Supported by broad-based disbursement growth, benign asset quality, and contained credit cost, MMFS reported a healthy 2QFY27. PAT was up 55% yoy to Rs8.82bn and AUM rose ~15% yoy to Rs1.47trn, aided by strong momentum in the non-wheels segment.
|
|||
| 22 Oct 2026 | Eternal |
Emkay
|
304.45 | 420.00 | 312.35 (-2.53%) | 37.95 |
Buy
|
||||
| 22 Oct 2026 | Bank Nifty |
SBI Securities
|
54925.70 |
Daily Note
|
|||||||
| 22 Oct 2026 | Nifty 50 |
SBI Securities
|
22687.65 |
Daily Note
|
|||||||
| 22 Oct 2026 | Nifty 50 |
invest4Edu
|
22687.65 |
Daily Note
|
|||||||
| 21 Oct 2026 | M&M Financial |
Motilal Oswal
|
287.60 | 375.00 | 297.45 (-3.31%) | 30.39 |
Buy
|
||||
| 21 Oct 2026 | Aditya Birla Sun Life AMC |
Motilal Oswal
|
904.15 | 1160.00 | 950.40 (-4.87%) | 28.30 |
Buy
|
||||
| 21 Oct 2026 | Hindalco Industries |
Motilal Oswal
|
885.60 | 1170.00 | 892.85 (-0.81%) | 32.11 |
Buy
|
Multiple growth levers to drive earnings inflection and deleveraging
Motilal Oswal
We maintain our positive stance on Hindalco Industries (HNDL), as the recent correction, driven by declining LME prices and supply normalization, appears largely priced in, while the long-term growth outlook remains intact.
|
|||
| 21 Oct 2026 | Emcure Pharma |
Motilal Oswal
|
1782.60 | 2330.00 | 1755.10 (1.57%) | 30.71 |
Buy
|
Domestic traction improves; overseas momentum intact
Motilal Oswal
We analyzed Emcure’s domestic formulation (DF) segment and observed green shoots of recovery in the past couple of months, led by gynecology, anti-infectives, cardiac and anti-diabetic, while key brands continued to deliver strong growth.
|
|||
| 21 Oct 2026 | Bank Nifty |
SBI Securities
|
54925.70 |
Daily Note
|